GWS
TRAW icon

Glassman Wealth Services’s Traws Pharma TRAW Stock Holding History

Glassman Wealth Services’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$86 – 2011
2022
Q4 		$86 Hold
5
– – ﹤0.01% 1892
2022
Q3 		$0 Hold
5
– – ﹤0.01% 2034
2022
Q2 		$0 Buy
+5
New +$169 ﹤0.01% 2055

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return

Glassman Wealth Services's TRAW Position: Q1 2023 in Review

Glassman Wealth Services sold out of Traws Pharma (TRAW) in Q1 2023, closing a stake of 5 shares — an estimated $86 sold.

Glassman Wealth Services first reported a position in TRAW in Q2 2022 and held it in 3 quarters. The position peaked at $86 in Q4 2022. 24 funds tracked by Wall St. Rank hold TRAW as of Q1 2023.

  • Glassman Wealth Services reported no remaining Traws Pharma position as of Q1 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 5 Traws Pharma shares in Q1 2023, an estimated $86.
  • Glassman Wealth Services first reported a position in Traws Pharma in Q2 2022 and held it in 3 quarters.
  • Glassman Wealth Services's Traws Pharma position peaked at $86 in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2023.

Based on Glassman Wealth Services's 13F filing for Q1 2023, filed 4 May 2023.